PD-34799-SA
Code | Size | Price |
---|
TAR-T24603-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24603-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24603-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
PD-34799-SA is an effective inhibitor of vasoconstrictor responses to sympathetic nerve stimulation.
CAS:
860385-36-0
Formula:
C10H17N3O5S
Molecular Weight:
291.32
Purity:
0.98
SMILES:
OS(O)(=O)=O.NC(=N)NCCCOc1ccccc1
References
1. Orchard A, Viljoen A, van Vuuren S. Antimicrobial Essential Oil Combinations to Combat Foot Odour. Planta Med. 2018 Mar 26. doi: 10.1055/a-0592-8022. [Epub ahead of print] PubMed PMID: 29579744.
2. Weiss R, Fernandez E, Liu Y, Strong R, Salmon AB. Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY). 2018 Mar 22. doi: 10.18632/aging.101401. [Epub ahead of print] PubMed PMID: 29579736.
3. Cirrincione LR, Penchala SD, Scarsi KK, Podany AT, Winchester LC, Back DJ, Khoo SH, Fletcher CV, Siccardi M, Else LJ. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Mar 12;1084:106-112. doi: 10.1016/j.jchromb.2018.03.023. [Epub ahead of print] PubMed PMID: 29579732.
4. Wang Q, Gao J, Wu X. Pseudoprogression and hyperprogression after checkpoint blockade. Int Immunopharmacol. 2018 Mar 23;58:125-135. doi: 10.1016/j.intimp.2018.03.018. [Epub ahead of print] Review. PubMed PMID: 29579717.